Cannabinoid receptor agonist shows potential protective effect on SARS-CoV-2-infected human heart cells As scientists continue to search for effective antidotes to direct and indirect damage caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a new preprint research paper posted to the bioRxiv* server demonstrates the potential of cannabinoid receptor agonists to alleviate myocardial damage in this condition even in the absence of any inhibitory effect on viral infection as such. The features of SARS-CoV-2 infection The SARS-CoV-2 virus appears to be a primarily respiratory virus, but it also brings about many other effects such as neurological signs and symptoms, gut symptoms, and cardiovascular features.